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Abstract
Genetic engineering is the most powerful technology of this century which is dramati-
cally revolutionizing the agriculture, health, pharmaceutical, and food industries all over 
the world. Transcriptomics and genetic engineering go hand in hand from the devel-
opment of a genetically modified organism (GMO) to its utilization by the humans. 
Transcriptome analysis is the analysis of messenger RNAs (mRNAs), which are pro-
duced by transcription of deoxyribonucleic acid (DNA) in an organism in response to 
a specific internal/external environment. Transcriptome analysis is not only useful to 
dig out the potential target genes for genetic modifications but also utilized to study the 
proper functioning of a genetically engineered gene, evaluation of the GMO for biosafety 
risks and for monitoring the presence and movement of GMO. Despite huge scope of 
genetic engineering, these manipulations can upset the natural balance of a genome by 
insertional, soma clonal, and pleiotropic effects of a foreign gene resulting in unintended 
alterations along with the targeted changes. The untargeted alterations pose risks to 
environment and health of animals and plants. In this chapter, the key advancements in 
the field of biotechnology and the relevant biosafety issues are reviewed. The advantages 
and limitations of the current methods used for the evaluation, monitoring, and regula-
tion of GMOs are discussed.
Keywords: genetic engineering, gene silencing, genetically modified organisms, unintended 
modifications, pleiotropic effects, enzyme-linked immunosorbent assay, soma clonal effects, 
next-generation sequencing
1. Introduction
Genetic engineering is an advanced field of biology that deals with modification of genomic 
deoxyribonucleic acid (DNA) in the living organisms to introduce desired traits to benefit man-
kind. Through genetic engineering, a DNA fragment (gene) is isolated from the donor organism 
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and transferred to the recipient where it can be transcribed into messenger RNA (mRNA) and 
translated to proteins by utilizing the recipient machinery. The donor protein in the recipient 
system performs its targeted function to modify the desired character of recipient plant, animal, 
or microorganism. Genomic DNA manipulations may involve addition of a foreign gene from 
another genome, deletion of an existing gene, or enhancing the expression of an indigenous 
gene. RNA interfering (RNAi) technology is used to silence the expression of an unwanted 
gene by inhibiting the mRNA availability for protein synthesis [1]. The genome-level genetic 
engineering approaches require an insight in the genome, transcriptome, and metabolome [2] 
of the organisms under study. Like all other applied fields, genetic engineering requires com-
prehensive information about the genome structure of the donor and recipient before genetic 
modification. Decision about the morphological character that needs to be improved, the choice 
of a particular donor and recipient species, genetic networks, and metabolic pathways involved 
in the expression of a specific trait need to be explored.
Transcriptome analysis is a robust and cost-efficient method which provides information 
about the internal biological processes, cellular biosynthesis, and metabolic functions of a 
cell, tissue, or living organism [3]. This technique can be utilized by the genetic engineering 
scientists for the identification and quantification of genetic factors which positively or nega-
tively regulate a particular trait of interest [4]. Comparison of gene expression profiles of an 
organism exhibiting the desired traits with the genetically similar organism lacking that trait 
can help in the identification of genetic factors involved in the development of that trait [5, 6]. 
These genetic factors might affect that trait positively or negatively. Enhanced accumulation 
of a particular transcript in the organism with desired phenotype as compared to the refer-
ence organism indicates that overexpression of that transcript is required for the exhibition of 
that trait. This phenomenon is called as positive regulation. In negative regulation, reduced 
expression of a gene is responsible for the exhibition of a desired trait [7, 8].
Positively regulated genes serve as genetic engineering tools for overexpression of a gene 
regulating a particular trait resulting in the introduction of that trait in genetically modified 
organism (GMO). For example, in transgenic cotton, expression of crystal protein (Cry10Aa) 
is responsible for resistance against boll weevil [9]. Advances in gene silencing technology 
through RNAi have led to utilization of genes which are negatively correlated with the 
desired traits. In cotton plant, seed-oil content increased by 16.7% by silencing GhPEPC1 gene 
through RNAi technology [8].
Transcriptome analysis and genetic engineering go hand in hand in the modern era of 
genetic improvements. Comparative transcriptional studies using single gene approaches 
or high-throughput approaches are used to identify the differentially expressed genes in a 
specific condition/organism as compared to reference. In single gene approaches, the expres-
sion of a gene of interest is quantified in different sets of conditions/tissues using northern 
blotting or reverse transcriptase polymerase chain reaction (RT-PCR). Northern blotting 
technique utilizes the gene-specific probes for comparative quantification of mRNAs of the 
target gene, whereas RT-PCR uses gene-specific primers to amplify and subsequently quan-
tify the mRNA molecules. High-throughput technologies have the power to measure and 
analyze the expression of all the genes in a set of conditions. Differential display reverse 
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transcriptase PCR (DDRT-PCR), gene expression microarray, and next-generation sequenc-
ing (NGS) techniques are high-throughput techniques which are currently used. DDRT-PCR 
can study the expression of hundreds of genes at the same time, whereas microarray and 
NGS can study the whole transcriptome in a single experiment. Expression microarrays can 
give insight of the comparative transcriptomics, whereas NGS can provide absolute quanti-
fication of each transcript. All these techniques help in the identification of genes which give 
differential expression under different conditions.
These identified genes serve as targets to be used in different genetic engineering events. 
These genes are manipulated in the living organisms to produce GMOs. The modified organ-
ism is tested for the proper functioning of the transgene by single gene transcriptional analy-
sis. Then the GMO is tested for the potential risks to the environment and human/animal 
health using targeted approaches which are biased and require preexisting knowledge of the 
risk. The comprehensive and unbiased assessment of the GMO should be done using global 
transcriptome analysis of the GMO with the commercial safe variety. After biosafety testing, 
GMO is released for commercialization and human/animal utilization. There is great deal of 
resentment and resistance against utilization of genetically altered organisms. Many govern-
ments have designed policies to properly monitor the presence and movement of GMOs. 
Transcriptional analysis is widely being utilized for the monitoring of various newly devel-
oped organisms.
2. Genetic engineering for human benefit
Genetic engineering is the field of science which is revolutionizing the world by manipulat-
ing the genome and transcriptome of living organisms to introduce desired traits in them. 
Since the commercialization of “Flavr Savr” tomato in 1994 [10], 357 GM crops belonging to 
27 species all over the world have been commercialized [11], and this number is increasing 
day by day. Genetic engineering is widely being used for the improvement of crops, animals, 
fungi [12], bacteria [13], and other organisms to benefit mankind. Insect resistance, herbicide 
resistance, disease resistance, and abiotic resistance are being incorporated in the industrially 
important crops to make them tolerant to stresses. Yield and nutritional content of food crops 
are being modified to improve the feed for humans and animals. Scientists [14] produced 
transgenic maize with overexpressing Oryza sativa myeloblastosis 55 (OsMYB55) gene and 
found that the transgenic maize became more tolerant to heat and drought stress through 
activating the expression of stress-responsive genes. Microorganisms (bacteria and fungi) are 
being genetically engineered for the production of useful enzymes [13], secondary metabo-
lites, beneficial oils [12], and antibiotics on commercial scale to be utilized in the pharmaceuti-
cal, food, and medical industry.
In 2010, 29 countries were growing genetically modified crops, and 31 countries had the 
approval to import GM crops. In USA, more than 94% of the cultivated soybean and cot-
ton while 92% of corn is genetically modified [15]. The commercialization of the first geneti-
cally modified animal “AquAdvantage Salmon” for food was approved recently in 2015 [16]. 
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 RNA-based genetic engineering technology is becoming more attractive after the approval of 
white button mushroom for commercialization without stringent testing by the USDA, as this 
technology does not involve the introduction of foreign DNA [17].
3. GMOs and biosafety issues
Due to the advancements in the field of biotechnology and genetic engineering, new varieties 
are extensively prevailing in the society. Despite their huge potential for human welfare, their 
commercialization is controversial. Many people perceive all the GMOs to be bad for their 
health and environment. People who are aware of the mechanism of genetic engineering are 
concerned about the unintended modifications and their effect on the soil microorganisms 
[18], plant-microbe interaction [19], and imbalances in the natural biosystems. GMO’s con-
troversy mainly revolves around environmental safety [20], human and animal health [21], 
concerns over interfering with nature [22], and patent issues [23].
Genetically modified organisms produced by genetic engineering or conventional plant 
breeding are targeted to enhance the desired commercial traits, but GMOs might exhibit unin-
tended traits as well. In the international meeting on “Genetic Basis of Unintended Effects in 
Modified Plants,” biotechnology industry, government, and academia emphasized that no 
genetic modification is without unintended effects whether conventional breeding or genetic 
engineering [24]. The source of unintended modifications could be attributed to gene inser-
tions or deletions involving deletion or disruption of endogenous genes and chimeric protein 
production which perform abnormal function. Genetic engineering approaches involving tis-
sue culturing and in vitro culturing pose the risk of soma clonal modifications arising from 
the genetic and epigenetic effects of in vitro cultures [25]. Pleiotropic effects may contribute 
to the unintended modifications if the transgene plays multiple roles or is the part of multiple 
pathways in an organism leading to the production of potentially harmful secondary metabo-
lites [26].
Biosafety policies involve principles, procedures, and rules devised and adapted for protect-
ing the environment and health of the individuals against potentially harmful metabolites and 
toxins. Biosafety involves containment of harmful material to avoid unintentional  exposure to 
toxic agents produced by genetically modified organisms [27].
4. Monitoring of GMOs
Due to the resentment of the consumers in utilizing GMOs for food and animal feed purposes, 
many governments have devised policies to give its people freedom over utilization of GMOs. 
Policies mainly revolve around detection, proper labeling, isolation of propagation area, and 
tracking of GMOs. International trading requires standardization of procedures and policies 
related to GMO monitoring and marketing among trading countries. Moreover, in order to 
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limit the entry of approved varieties across the borders of a country, proper monitoring of 
GMOs is required.
The first step in the monitoring of GMO is the detection of transgene in an organism under 
question. Many methods are being used to detect the genetically modified varieties. GMOs 
produced by insertion of DNA fragments can be detected by protein-based assays [Enzyme-
linked immunosorbent assay (ELISA), Western blotting, etc.] or nucleotide-based assays 
including PCR. PCR-based detection is the most sensitive method which makes use of 
sequence-specific primers [28]. Due to the abundance of GMOs in the market, it has become 
very difficult to keep the sequence information of all the transgenes. The advanced high-
throughput technologies for GMO detection/monitoring are developed to detect multiple 
transgenes or related nucleotide components (promoter, enhancer, and terminator) of the 
cassette [29, 30] in a single experiment. For rapid PCR at atmospheric temperature, various 
methods have been developed [31]. DNA microarray chips are being developed which con-
tain the probes against all the transgenes present in the commercial varieties [32]. Sampling 
and hybridization of DNA of a variety under question can detect the presence of any trans-
gene. More efficient, sensitive, and robust methods are required for proper monitoring.
All the above methods are used for the detection of DNA insertion in the transgenic organ-
isms. However, in the RNA-based GMOs, the detection of transgene requires transcriptomic 
approaches. Transcriptional methods including RT-PCR, gene expression microarray, and 
RNA-seq can detect all types of GMOs produced through RNA- or DNA-based methods. 
In transcriptomic approaches, RNA is isolated from the sample and reverse transcribed to 
produce complementary DNA (cDNA). Due to resemblance in the biochemical properties of 
RNA and DNA, DNA is often present in the RNA preparations which is eliminated by treat-
ing the sample with DNase enzyme. By avoiding this step of DNase treatment, we get both 
RNA and DNA in the sample. This crude RNA is transcribed and RT-PCR is used for the 
detection of RNA or DNA of the transgene.
5. Validation of genetically modified organisms
The developers of GMOs are required to assess the phenotypic and molecular characteristics 
of modified organisms. Many countries have adopted regulations for commercialization of 
GMOs which mainly include the comprehensive risk assessment of the new organism before 
field trials, to be used as feed/food or before release to the environment. These risk assessment 
methods mainly involve the comparison of the agronomic traits, composition, animal nutri-
tion, and production of toxins of the new product with commercially available for multiple 
years and at multiple sites. But these assessments are targeted and require the prior informa-
tion about the risk. The untargeted risks can be left without evaluation with the potential to 
harm the environment and health.
During the screening and selection of a GMO, the emphasis is given to the insertion of the 
transgene as a single copy without disruption of an endogenous gene, preserving the gene 
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cassette and the absence of vector backbone. Safety of the GMO is tested on a very limited 
scale only when the GMO is ready to be commercialized. The main focus of the biosafety 
studies is limited to the assessment of the effect of the GMO on the consumer health and 
safety. The phenotypic and agronomic traits of the newly produced plant and a genetically 
similar organism are compared [33], but thorough profiling of the genetically modified organ-
ism is lacking.
Newly produced plants by genetic engineering and other genetic methods should not only 
be assessed by target-based approaches as these assessments are biased and cannot recog-
nize the unintended risks thoroughly [34]. Genome-wide approaches like transcriptome 
analysis, proteome analysis, or metabolome analysis have the advantage of being unbiased 
and robust [35–37] and provide a lot of information about the new plant variety. Scientists 
compare the protein profiles of genetically modified organisms with their wild types to 
identify the aberrant proteins. Proteome of a commercial variety of maize was compared 
with the isogenic transgenic line which was resistant to European corn borer by express-
ing Cry1Ab gene [38]. The results spotted unwanted/unintended protein expression in the 
transgenic lines and suggested for the untargeted evaluation of the new transgenic organ-
isms. Other studies using proteomic or transcriptomic approaches to compare the GMO 
with the wild type found only intended alterations [7], while no unintended changes were 
found.
Unintended changes arising as a result of pleiotropic effects of genetic modification are not 
always harmful. A group of scientists has performed transcriptome analysis in GMO lines 
developed for enhanced insect attraction in Arabidopsis and compared it with naturally occur-
ring non-GMO lines to identify transcriptional distance between the two groups [39]. They 
identified that the pleiotropic effects of gene insertion are equivalent to the gene expres-
sion changes naturally occurring in Arabidopsis indicating that the specific modified lines of 
Arabidopsis were equally safe as naturally occurring lines. Thus unbiased and untargeted risk 
assessment of GMOs through newly developed “omic” techniques is necessary [40] before its 
release in the environment or trials for human and animal use.
6. Transcriptome analysis for GMO validation
Unbiased detection of unintended effects of transgene in a genetically modified organism 
requires comparison of transcriptome [41], proteome [38] and metabolome [40] of the modi-
fied organism with the isogenic unmodified organism. The thorough profiling helps in the 
identification of genes, proteins, and metabolites modified in the newly developed organism. 
By digging the gene networks, protein functions, and metabolic processes of the altered bio-
molecule, scientists can depict the effects of GMO on the environment, health, and nutrition 
of the consumer. The absence of unintended aberrations in the biomolecules declares the new 
variety as safe, whereas the presence of unintended aberrations does not declare it to be unsafe 
but indicates that the variety requires more targeted validation before commercialization [7].
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Transcriptome analysis stands out of the other omic-based approaches due to its comparative 
simplicity and cost efficiency. Latest technologies of gene expression microarray and NGS 
are commonly used for global transcriptional profiling of GMO and wild-type ecotype for 
transcriptional equivalence. Gene expression microarray involves the use of chips containing 
probes which represent the complete genome of an organism under study. Hybridization 
of these chips with fluorescently labeled cDNA can identify the genes which are differen-
tially expressed between GMO and wild type. NGS technologies involve sequencing and 
quantification of nucleotides at the same time. RNA-seq is the type of NGS which specifi-
cally deals with the transcriptional studies. Gene expression microarray and RNA-seq have 
proved themselves equally for the detection of intended and unintended effects. However, 
both approaches have some advantages and disadvantages. Microarray experiments are com-
paratively cheaper and easier than RNA-seq. But the chips are commercially available only 
for a limited number of organisms, and custom printed chips require the genome sequence 
information of the specific organism. The full power of this technology can only be utilized 
for sequenced genomes. While RNA-seq is the only technology which can sequence as well as 
quantify the mRNA libraries of unsequenced genomes. Moreover, RNA-seq provides us the 
absolute quantification as compared to microarray which give comparative quantification. 
Table 1 shows some examples where scientists have utilized these transcriptomic approaches 
for GMO validation.
Gene expression microarray and RNA-seq methods not only identify the unintended effects 
of genetic engineering but are also useful in elucidating the mechanism of action of a trans-
gene. Pathway analysis and gene ontology analysis of modified genes lead to the evaluation 
of molecular basis of phenotypic changes in the newly produced organisms [48]. Transgenic 
variety of papaya (Carica papaya L.) fruit which was resistant to papaya ring spot virus (PRSV) 
was evaluated against its progenitor variety through RNA-seq analysis. The transcriptional 
profiles revealed the transcription factors, signaling pathways which were responsible for the 
stress tolerance and pathogen resistance [43].
Biotic and abiotic stress tolerance is a complex mechanism involving many gene networks 
and pathways causing changes in the morphology and physiology. Stress-related transcrip-
tion factors which can bind to the promoters of multiple genes are largely used as transgenes 
to produce stress-tolerant GMOs. Genetically engineered crops for tolerance against stresses 
are difficult to get approval for commercialization due to increased risk of pleiotropic effects. 
Global transcriptome analysis can identify all the pathways affected by any kind of genetic 
modification and targets for risk assessment.
Transcriptomic approaches have an added benefit of detection of gene silencing in the GMOs 
produced by gene silencing technology. RNAi-based technologies where double-stranded 
RNA targeting a specific gene is introduced in an organism. This RNA after being processed 
in the recipient organism is converted into smaller piece of nearly 21–22 nucleotides. These 
RNAs reach their targets and inhibit the translation of specific messenger RNA into respec-
tive proteins, thus functionally silencing the genes post-transcriptionally. The increasing 
popularity of this technology is due to its ability to not affect the genome of the GMO [49].




The newly produced GMOs could be very harmful for the environment, microbial life, and 
human and animal health, but they are not always harmful. The producers of genetically 
modified organisms should analyze the global transcriptional profiles of the GMO in com-
parison with the safe commercial variety to assess the presence or absence of unintended 
modifications. This data would also provide comprehensive and unbiased information about 
the metabolic pathways altered in the new organism that can be helpful in designing the strat-
egy for biosafety risk assessment of GMOs.
Transcriptome analysis is very useful for detection and evaluation of transgenics produced 
by RNAi technology or transcription factor transformations. However, evaluation of gene 
expression is a very sensitive phenomenon and variable in different tissues and changing 
conditions. So, for transcriptional analysis, the selection of suitable sample and experimental 
conditions is critical for reliable results.
Organism Altered trait Gene Method of 
evaluation
References
Wheat Drought and salt 
tolerance
Glycine max drought-responsive 
element-binding factor (GmDREB1)
RNA-seq Jiang et al. [7]
Arabidopsis Drought tolerance Abscisic acid-responsive element 
binding factor 3 (ABF3)
Expression 
microarray
Abdeen et al. [42]
Arabidopsis Insect attraction Farnesyl diphosphate synthase 1 
long isoform (FPS1L), nerolidol 
synthase 1 from Fragaria ananassa 
(FaNES1), short (cytosolic) isoform 
of 3-hydroxy-3-methylglutaryl 
coenzyme A reductase 1 (HMGRIS)
Expression 
microarray
Houshyani et al. [39]
Papaya Resistance against 
papaya ring spot virus
Coat protein (CP) of PRSV RNA-seq Fang et al. [43]
Maize Insect resistance Cry1Ab Expression 
microarray
Coll et al. [44]
Rice Antifungal protein Antifungal protein (AFP) Expression 
microarray
Montero [45]
Barley Defense against stresses Endochitinase Expression 
microarray
Kogela [46]
Soybean Human and viral protein 
production in plants
Human myelin basic protein 
(hMBP), human thyroglobulin 
protein (hTG), mutant nontoxic 
staphylococcal enterotoxin B gene 
(mSEB)
RNA-seq Lambirth et al. [47]
Table 1. Evaluation of GMOs by transcriptome analysis.
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